![]() |
市場調查報告書
商品編碼
1511346
到 2030 年蝨子治療市場預測:按產品、治療方法、配方、分銷管道、應用、最終用戶和地區進行的全球分析Lice Treatment Market Forecasts to 2030 - Global Analysis By Product, Treatment Method, Formulation, Distribution Channel, Application, End User and By Geography |
根據 Stratistics MRC 的數據,2024 年全球蝨子治療市場規模為 12.8 億美元,預計將以 6.5% 的複合年成長率成長,到 2030 年將達到 17.6 億美元。
蝨子治療涉及消滅或去除蝨子,蝨子是通常生活在頭皮、身體和生殖器上的寄生蟲。這個過程通常涉及使用含有Permethrin和除蟲菊酯等化學物質的藥用洗髮精、乳霜和乳液來殺死蝨子及其卵(頭蝨)。此外,通常建議用細齒梳子梳理頭髮,以物理方式去除蝨子和蝨子卵。良好的衛生習慣和徹底清洗寢具、服裝類和髮飾等個人物品對於防止再次感染和提供有效的治療至關重要。
根據 CDC 2021 年 8 月發表的報導,美國利斯診所已使用熱空氣進行了超過 75 萬次有效的頭蝨治療,成功率超過 99%。
蝨子患病率高
隨著蝨子流行的增加,對藥用洗髮精、乳霜和特殊梳子等治療解決方案的需求也在增加。這種需求推動了研發創新和投資,從而推出更有效、更方便的治療方法。此外,醫療保健專業人員和公眾對這一問題的認知不斷提高,將導致更多地採用蝨子治療產品,最終刺激市場的成長和擴張,以滿足不斷成長的需求。
對潛在副作用的擔憂
對蝨子治療潛在副作用的擔憂包括皮膚刺激、過敏反應以及Permethrin和除蟲菊酯等化學成分的毒性。這些擔憂可能導致不願意使用傳統治療方法、傾向於替代治療方法或完全避免治療。這種猶豫不決會減少對蝨子治療藥物產品的需求,從而限制市場成長,限制製造商的產生收入,並抑制市場擴張。
醫療保健支出增加
隨著更多的財政資源分配給醫療保健,個人和衛生系統可以更好地購買蝨子治療劑、洗髮精和相關產品。此外,對醫療基礎設施的投資增加通常會改善宣傳宣傳活動、教育計劃以及專門的皮膚科和感染疾病設施,所有這些都有助於增加對蝨子治療解決方案的需求。這一趨勢最終支持了蝨子治療市場的擴張。
家庭療法越來越受歡迎
治療蝨子的家庭療法越來越受歡迎,轉移了藥品的需求,從而削弱了市場。家庭療法與傳統治療方法直接競爭,並減少了製藥公司的銷售。此外,依賴檢驗的家庭療法可能會惡化並延長蝨子的侵擾。消費者偏好的這些變化減少了經過醫學驗證的治療方法的採用,並阻礙了蝨子治療藥物製造商的商機,從而限制了市場成長。
COVID-19 的影響
COVID-19 大流行對蝨子治療市場產生了多種影響。儘管衛生意識的提高和社交距離措施最初降低了蝨子發病率,但醫療保健服務的中斷和經濟的不確定性正在阻礙市場的成長。此外,向遠距工作和虛擬學校的轉變可能改變了蝨子暴露的動態。整體而言,疫情帶來了供應鏈中斷和消費行為變化等複雜性,對蝨子治療市場產生了不可預測的影響。
預計預測期內化療領域規模最大
化療領域預計將出現良好的成長。化學蝨子治療方法通常包括Permethrin或除蟲菊酯等殺蟲劑,它們可以瞄準並殺死蝨子及其卵。這些產品有多種形式,包括洗髮精、乳霜和乳液,可直接塗布在頭皮或受影響的區域。儘管有效,但由於擔心皮膚刺激和毒性等潛在副作用,不鼓勵使用。此外,蝨子菌株中抗藥性細菌的發展也是化學處理的一個挑戰。
洗髮精領域預計在預測期內複合年成長率最高。
預計洗髮精細分市場在預測期內將以最高的複合年成長率成長。蝨子治療洗髮精採用Permethrin和除蟲菊酯等活性成分配製而成,可殺死蝨子及其卵(蝨子)。這些洗髮精塗布在濕髮上,放置一定時間,然後洗掉。根據配方的不同,可能需要重複施用才能徹底根除。儘管有效,但對化學物質接觸和抗藥性細菌發展的擔憂正在導致替代治療方法的發展,例如天然成分和酶基洗髮精。
由於人口密度、衛生習慣和經濟發展,亞太地區預計在預測期內將佔據最大的市場佔有率。由於人口密度高和獲得醫療保健的水平不同,各國對蝨子治療產品的需求各不相同。一些地區的快速都市化和可支配收入的增加也推動了市場的成長。此外,政府措施和醫療保健基礎設施發展在塑造亞太地區的市場前景方面發揮著至關重要的作用。
由於人們對衛生和醫療保健標準的認知不斷提高,預計北美在預測期內的複合年成長率最高。兒童(尤其是學校)蝨子感染率的上升正在推動市場擴張。此外,技術進步以及有機和自然療法的引入進一步使市場格局多樣化。專注於有效性、安全性和便利性的相關人員不斷創新,以滿足不斷變化的消費者需求並推動北美市場的持續成長。
According to Stratistics MRC, the Global Lice Treatment Market is accounted for $1.28 billion in 2024 and is expected to reach $1.76 billion by 2030 growing at a CAGR of 6.5% during the forecast period. Lice treatment involves the removal or eradication of parasitic lice infestations, typically found on the scalp, body, or pubic area. This process commonly includes the use of medicated shampoos, creams, or lotions containing chemicals like permethrin or pyrethrin to kill the lice and their eggs (nits). Additionally, combing through the hair with a fine-toothed comb to physically remove lice and nits is often recommended. Proper hygiene practices and thorough cleaning of personal items such as bedding, clothing, and hair accessories are essential to prevent reinfestation and ensure effective treatment.
According to a CDC article published in August 2021, Lice Clinics of America have accomplished administering over 750,000 effective head lice treatments through the utilization of heated air, with a success rate beyond 99 percent.
High prevalence of lice infestations
Increased instances of infestations create a greater demand for treatment solutions, including medicated shampoos, creams, and specialized combs. This demand encourages innovation and investment in research and development, leading to the introduction of more effective and convenient treatment options. Furthermore, heightened awareness of the problem among healthcare professionals and the public amplifies the adoption of lice treatment products, ultimately fueling market growth and expansion to cater to the rising needs.
Concerns about potential side effects
Concerns about potential side effects in lice treatment include skin irritation, allergic reactions, and toxicity from chemical ingredients like permethrin or pyrethrin. These worries can deter individuals from using conventional treatments, leading to a preference for alternative remedies or avoidance of treatment altogether. Such hesitations diminish market growth by reducing demand for pharmaceutical lice treatment products, thereby limiting revenue generation for manufacturers and impeding market expansion.
Rising healthcare expenditure
With more financial resources allocated to healthcare, individuals and healthcare systems are better equipped to purchase lice treatment medications, shampoos, and related products. Additionally, greater investment in healthcare infrastructure often leads to improved awareness campaigns, educational programs, and healthcare facilities specializing in dermatology and infectious diseases, all of which contribute to a higher demand for lice treatment solutions. This trend ultimately supports the expansion of the lice treatment market.
Growing popularity of home remedies
The growing popularity of home remedies for lice treatment undermines the market by diverting demand away from pharmaceutical products. Home remedies compete directly with traditional treatments, reducing sales for pharmaceutical companies. Moreover, reliance on unverified home remedies can prolong infestations, exacerbating the spread of lice. This shift in consumer preference limits market growth by diminishing the adoption of medically proven treatments and hindering revenue opportunities for lice treatment manufacturers.
Covid-19 Impact
The covid-19 pandemic has had a mixed impact on the lice treatment market. While increased hygiene awareness and social distancing measures initially reduced lice transmission rates, disruptions in healthcare access and economic uncertainty have hindered market growth. Additionally, shifts towards remote work and virtual schooling may have altered lice exposure dynamics. Overall, the pandemic has introduced complexities such as supply chain disruptions and changes in consumer behaviour, influencing the lice treatment market unpredictably.
The chemical treatments segment is expected to be the largest during the forecast period
The chemical treatments segment is estimated to have a lucrative growth. Chemical lice treatments typically contain insecticidal agents like permethrin or pyrethrin, which target and kill lice and their eggs. These products are available in various forms such as shampoos, creams, or lotions and are applied directly to the scalp or affected area. While effective, concerns about potential side effects, such as skin irritation or toxicity, have led to hesitations in usage. Resistance development among lice strains is also a growing challenge for chemical treatments.
The shampoos segment is expected to have the highest CAGR during the forecast period
The shampoos segment is anticipated to witness the highest CAGR growth during the forecast period. Lice treatment shampoos are formulated with active ingredients like permethrin or pyrethrin, which kill lice and their eggs (nits). These shampoos are applied to wet hair, left on for a specified duration, and then rinsed out. Some formulations may require repeat applications to ensure thorough eradication. While effective, concerns about chemical exposure and the development of resistance have prompted the development of alternative treatments, including natural or enzyme-based shampoos.
Asia Pacific is projected to hold the largest market share during the forecast period due to population density, hygiene practices, and economic development. With densely populated areas and varying levels of access to healthcare, demand for lice treatment products fluctuates across countries. Rapid urbanization and increasing disposable income in some areas also drive market growth. Additionally, government initiatives and healthcare infrastructure improvements play pivotal roles in shaping the market landscape across the Asia-Pacific region.
North America is projected to have the highest CAGR over the forecast period, owing to increasing awareness about hygiene and healthcare standards. Rising incidence of lice infestations, particularly among children in school settings, fuels market expansion. Moreover, technological advancements and the introduction of organic and natural remedies further diversify the market landscape. With a focus on efficacy, safety, and convenience, stakeholders continually innovate to address evolving consumer needs, fostering sustained market growth in North America.
Key players in the market
Some of the key players profiled in the Lice Treatment Market include Prestige Brands Holdings, Inc., Bayer AG, Sanofi SA, Perrigo Company plc, Insight Pharmaceuticals Corporation, Reckitt Benckiser Group plc, Arbor Pharmaceuticals, LLC, Tec Laboratories, Inc., Tyratech Inc., Quantum Health, Alliance Pharma plc, Omega Pharma, Thornton & Ross Ltd, LaCorium Health, Luminox Healthcare and ParaPRO LLC.
In April 2022, Arbor Development LLC announced the completion of the third-party clinical study that exhibits a remarkable 95% efficacy rate through the utilization of their cutting-edge, exclusive technology H.A.L.T.
In August 2021, ParaPRO announced the U.S. FDA approval for Natroba (spinosad) Topical Suspension, 0.9%, making it the inaugural product for treating scabies now accessible within the United States.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.